Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NBIX | B | Neurocrine Biosciences, Inc. | -0.75 | |
REGN | C | Regeneron Pharmaceuticals, Inc. | 0.78 | |
GMED | C | Globus Medical, Inc. | 0.44 | |
SVRA | C | Savara, Inc. | -5.13 | |
XTLB | C | XTL Biopharmaceuticals Ltd. | 2.92 | |
TGTX | C | TG Therapeutics, Inc. | -0.38 | |
PULM | C | Pulmatrix, Inc. | 1.03 | |
ICLR | D | ICON plc | 0.59 | |
CLDX | D | Celldex Therapeutics, Inc. | -1.51 | |
ALNY | D | Alnylam Pharmaceuticals, Inc. | -1.53 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Biotechnology
Monoclonal Antibodies
Pain
Antibody Drug Conjugate
Cancer
Cardiovascular Disease
Cholesterol
Clinical Research
Cystic Fibrosis
Disorders
Immunology
Life Sciences
Monoclonal Antibody
Organ Systems
Pharmaceutical Products
Schizophrenia
Treatment Of Cancer
Vascular Disease
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EIRL | A | iShares MSCI Ireland Capped ETF | 20.26 | |
BBH | C | Market Vectors Biotech ETF | 16.7 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 16.6 | |
IBB | D | iShares Nasdaq Biotechnology Index Fund | 11.59 | |
IBBQ | C | Invesco Nasdaq Biotechnology ETF | 11.56 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Biotechnology
Monoclonal Antibodies
Pain
Antibody Drug Conjugate
Cancer
Cardiovascular Disease
Cholesterol
Clinical Research
Cystic Fibrosis
Disorders
Immunology
Life Sciences
Monoclonal Antibody
Organ Systems
Pharmaceutical Products
Schizophrenia
Treatment Of Cancer
Vascular Disease
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles